Downing FOUR VCT plc Portfolio Update
04 June 2021 - 12:42AM
UK Regulatory
TIDMD467
Downing FOUR VCT plc (the "Company")
LEI: 21380035MV1VRYEXPR95
3 June 2021
Portfolio Update
The Directors of the Company are pleased to report that Generalist and
Healthcare Share portfolio company, Arecor Therapeutics ("Arecor"), has
today had its ordinary shares admitted to trading on AIM. The admission
follows a successful GBP20.0 million placing of new shares at a price of
226 pence per ordinary share (the "placing price").
Based on the placing price, the values of the Company's Generalist and
Healthcare Share pools' holdings in Arecor have increased by
approximately 0.9p per Generalist Share and 8.0p per Healthcare Share.
This is equivalent to increases of 1.3% and 11.4% in the unaudited NAVs
of the Generalist and Healthcare Share pools respectively, as at 28
February 2021 (being the most recent NAVs announced by the Company).
Enquiries:
Grant Whitehouse
Downing LLP
Company Secretary
020 7630 4333
(END) Dow Jones Newswires
June 03, 2021 10:42 ET (14:42 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Thames Ventures Vct 2 (LSE:D467)
Historical Stock Chart
From Apr 2024 to May 2024
Thames Ventures Vct 2 (LSE:D467)
Historical Stock Chart
From May 2023 to May 2024